Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 159

1.

Epstein-Barr virus LMP1 modulates lipid raft microdomains and the vimentin cytoskeleton for signal transduction and transformation.

Meckes DG Jr, Menaker NF, Raab-Traub N.

J Virol. 2013 Feb;87(3):1301-11. doi: 10.1128/JVI.02519-12. Epub 2012 Nov 14.

2.

CD63 Regulates Epstein-Barr Virus LMP1 Exosomal Packaging, Enhancement of Vesicle Production, and Noncanonical NF-κB Signaling.

Hurwitz SN, Nkosi D, Conlon MM, York SB, Liu X, Tremblay DC, Meckes DG Jr.

J Virol. 2017 Feb 14;91(5). pii: e02251-16. doi: 10.1128/JVI.02251-16. Print 2017 Mar 1.

3.

Unique signaling properties of CTAR1 in LMP1-mediated transformation.

Mainou BA, Everly DN Jr, Raab-Traub N.

J Virol. 2007 Sep;81(18):9680-92. Epub 2007 Jul 11.

4.

Src kinase and Syk activation initiate PI3K signaling by a chimeric latent membrane protein 1 in Epstein-Barr virus (EBV)+ B cell lymphomas.

Hatton O, Lambert SL, Krams SM, Martinez OM.

PLoS One. 2012;7(8):e42610. doi: 10.1371/journal.pone.0042610. Epub 2012 Aug 3.

5.

Latent infection membrane protein transmembrane FWLY is critical for intermolecular interaction, raft localization, and signaling.

Yasui T, Luftig M, Soni V, Kieff E.

Proc Natl Acad Sci U S A. 2004 Jan 6;101(1):278-83. Epub 2003 Dec 26.

7.
8.
9.

In nasopharyngeal carcinoma cells, Epstein-Barr virus LMP1 interacts with galectin 9 in membrane raft elements resistant to simvastatin.

Pioche-Durieu C, Keryer C, Souquère S, Bosq J, Faigle W, Loew D, Hirashima M, Nishi N, Middeldorp J, Busson P.

J Virol. 2005 Nov;79(21):13326-37.

10.

A novel dominant-negative mutant form of Epstein-Barr virus latent membrane protein-1 (LMP1) selectively and differentially impairs LMP1 and TNF signaling pathways.

Adriaenssens E, Mougel A, Goormachtigh G, Loing E, Fafeur V, Auriault C, Coll J.

Oncogene. 2004 Apr 8;23(15):2681-93. Erratum in: Oncogene. 2004 Oct 21;23(49):8184.

PMID:
14767477
11.

LMP1 strain variants: biological and molecular properties.

Mainou BA, Raab-Traub N.

J Virol. 2006 Jul;80(13):6458-68.

12.

Regulation of Latent Membrane Protein 1 Signaling through Interaction with Cytoskeletal Proteins.

Holthusen K, Talaty P, Everly DN Jr.

J Virol. 2015 Jul;89(14):7277-90. doi: 10.1128/JVI.00321-15. Epub 2015 May 6.

14.

Activation of the FGFR1 signalling pathway by the Epstein-Barr virus-encoded LMP1 promotes aerobic glycolysis and transformation of human nasopharyngeal epithelial cells.

Lo AK, Dawson CW, Young LS, Ko CW, Hau PM, Lo KW.

J Pathol. 2015 Oct;237(2):238-48. doi: 10.1002/path.4575. Epub 2015 Aug 3.

PMID:
26096068
15.

Latent membrane protein 1 of Epstein-Barr virus activates the hTERT promoter and enhances telomerase activity in B lymphocytes.

Terrin L, Dal Col J, Rampazzo E, Zancai P, Pedrotti M, Ammirabile G, Bergamin S, Rizzo S, Dolcetti R, De Rossi A.

J Virol. 2008 Oct;82(20):10175-87. doi: 10.1128/JVI.00321-08. Epub 2008 Aug 6.

16.

Epstein-Barr virus latent membrane protein 1 represses DNA repair through the PI3K/Akt/FOXO3a pathway in human epithelial cells.

Chen YR, Liu MT, Chang YT, Wu CC, Hu CY, Chen JY.

J Virol. 2008 Aug;82(16):8124-37. doi: 10.1128/JVI.00430-08. Epub 2008 Jun 4.

17.
18.
19.
20.

Supplemental Content

Support Center